Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Hoffmann-La Roche
Scientific Title
A Phase IB/II Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus CHOP in Patients With Follicular Lymphoma or Diffuse Large B-Cell Lymphoma